NO: COPD and beyond

Thorax

Volumn 52, Issue SUPPL. 3, 1997, Pages

  Jones, Andrew T ^a   Evans, T W ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE; OXYGEN;

AMBIENT AIR; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPOXIC LUNG VASOCONSTRICTION; INHALATIONAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; LUNG VENTILATION PERFUSION RATIO; OXYGEN BREATHING; PRIORITY JOURNAL;

EID: 0030763575     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.2008.s16     Document Type: Article

References (69)

1. Barberà JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 1996;347:436-40.
2. Futchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholme. Nature 1980; 288:373-6.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 1987;327:524-6.
4. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chauduri G. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-4.
5. Moncada S, Higgs A. The L-arginine pathway. N Engl J Med 1993;329: 2002-12.
6. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide, physiology, pathophysiology and pharmacology, Pharmacol Rev 1991;43:104-42.
7. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994;298:244-58.
8. Stammler JS, Singei DJ, Loscaizo J. Biochemistry of nitric oxide and its redox activated forms. Science 1992;258:1848-902.
9. Chand N, Alchera BM. Acetylcholine and bradykinin relax intrapulmonary arteries by acting on endothelial cells: role in lung vascular diseases. Science 1981;213:1376-9.
10. Greenburg B, Rhoden K, Barnes PJ. Endothelium dependent relaxation of human pulmonary arteries. Am J Physiol 1987;252:H434-8.
11. Leeman M. Pulmonary vascular regulation by endogenous nitric oxide. In: Fink MP, Payen D, eds. Role of nitric oxide in sepsis and ARDS. Berlin: Springer, 1996:308-14.
12. Hampl V, Archer SL, Nelson DP, Weir EK. Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure J Appl Physiol 1993;75:1748-57.
13. Euler von US, Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 1946;12:301-14.
14. Voekel NF. Mechanisms of hypoxic pulmonary vasoconstriction. Am Rev Respir Dis 1986;133:1186-45.
15. Madden JA, Vadula M, Kurup VP. Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells. Am J Physiol 1992;263:L384-41
16. Weir KE, Archer SL. The mechanism of acute hypoxic vasoconstriction: the tale of two channels. FASEB J 1995;9:183-4.
17. Hampl V, Archer SL. The role of endogenous nitric oxide in acute hypoxic pulmonary vasoconstriction. In: Lung biology in health and disease: nitric oxide and the lung. 1997;98:113-35.
18. Hampl V, Cornfield DN, Cowan MJ, Archer SL. Hypoxia potentiates NO synthesis and transiently increases cytosolic calcium levels in pulmonary endothelial cells. Eur Respir J 1995;8:515-22.
19. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1984;83: 1774-7.
20. Barret ML, Willis AL, Vane JR. Inhibition of platelet-derived mitogen release by nitric oxide (EDRF). Agents Actions 1984;27:188-91.
21. Dinh-Xuan AT, Higenbottom TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt YA, et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 1991;324:1534-47.
22. Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981;36:752-8.
23. Riley RL, Himmelstein A, Morley HL, Motley HL, Weiner HM, Cournand A. Studies of the pulmonary circulation at rest and during exercise in normal individuals and in patients with chronic obstructive pulmonary disease. Am J Physiol 1948;152:372-90.
24. Weitzenblum E, Hirth C, Roselin N, Vandevenne A, Oudet P. Les modifications hemodynamiques pulmonaires au cours de l'insuffisance respiratoire aigue des bronchopneumopathies chroniques. Respiration 1971;28:539-54.
25. Fletcher EC, Levin DC. Cardiopulmonary haemodynamics during sleep in subjects with chronic hypoxic pulmonary disease: the effect of short- and long-term oxygen. Chest 1984;85:6-14.
26. MacNee W. Pathohysiology of cor pulmonale in chronic obstructive pulmonary disease (Part 1). Ant J Respir Crit Care Med 1994;150: 833-52.
27. Weitzenblum E, Loiseau A, Hirth C, Mirhom R, Rasaholinjanahary J. Course of pulmonary haemodynamics in patients with chronic obstructive pulmonary disease. Chest 1979;75:656-62.
28. Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1:681-6.
29. Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981;36:752-8.
30. France AJ, Prescott RJ, Biernacki W, Muir AL, MacNee W. Does right ventricular function predict survival in patients with chronic obstructive pulmonary disease. Thorax 1988;43:621-6.
31. Roca J, Wagner PD. Principles and information content of the multiple inert gas elimination technique. Thorax 1993;49:815-24.
32. Wagner PD, Dantzker R, Dueck JL, West JB. Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J Clin Invest 1977;59:203-16.
33. Barberà JA, Ramirez J, Roca J, Wagner PD, Sanchez-Lloret J, Rodriguez-Roisin R. Lung structure and gas exchange in mild chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141:895-901.
34. Agusti AGN, Barberà JA, Roca J, Wagner PD, Guitart R, Rodriguez-Roisin R. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest 1990; 97:268-75.
35. Ferrer A, Roca J, Barberà JA, Agusti AGN, Rodriguez-Roisin R. Pattern and time-course of ventilation-perfusion mismatch during exacerbation of chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141:A929.
36. Reeves JT. Hope in primary pulmonary hypertension. N Engl J Med 1980;302:112-3.
37. Weitzenblum E, Kessler R, Oswald M, Fraisse P. Medical treatment of pulmonary hypertension in chronic lung disease. Eur Respir J 1994; 7:148-52.
38. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease (Part II). Am J Respir Crit Care Med 1994;150: 1158-68.
39. Melot C, Hallemans R, Naeije R, Mols P, Lejeune P. Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984;130:612-6.
40. Nocturnal Oxygen Therapy Group. Continuous or nocturnal oxygen in hypoxaemic chronic obstructive lung disease. Ann Intern Med 1980; 93:391-8.
41. Timms RM, Khaja FU, Williams GW and the Nocturnal Oxygen Therapy Trial Group. Haemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985;102: 29-36.
42. Weitzenblum E, Sautageau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in chronic obstructive pulmonary disease. Am Rev Respir Dis 1985;131:493-8.
43. Hogmann M, Frostell CG, Hedenstrom H, Hedenstierna G. Inhalation of nitric oxide modulates human bronchial tone. Am Rev Respir Dis 1993;148:1474-8.
44. Frostell C, Fractacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic vasoconstriction. Circulation 1991;83:2038-47.
45. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic vaso-constriction without causing systemic vasodilation. Anaesthesiology 1993;78:427-35.
46. Pison U, Lopez FA, Heidelmeyer CF, Rossaint R, Falke KJ. Inhaled nitric oxide reverses hypoxic vasoconstriction without worsening gas exchange. J Appl Physiol 1993;74:1287-92.
47. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338:1173-4.
48. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
49. Roberts JD, Polaner DM, Lang P, Zapol W. Inhaled nitric oxide in persistent pulmonary hypertension of the new born. Lancet 1992;340: 818-9.
50. Roberts JD, et al. for the Inhaled Nitric Oxide Study Group. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997;336:605-10.
51. Roberts JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993;87:447-53.
52. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide in adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
53. Danztker DR, Brook CJ, Dehart P, Lynch JP, Weg JG. Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis 1979;120:1039-52.
54. McCormack DG, Crawley D, Barnes PJ, Evans TW. Bleomycin induced acute lung injury in rats selectively abolishes hypoxic pulmonary vasoconstriction: evidence against a role for platelet-activating factor. Aw Rev Respir Dis 1990;82:A485.
55. Adnot S, Kouyoumdjian C, Defouilloy ?, Andrivet P, Sediame S, Herigault R, et al. Haemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am Rev Respir Dis 1993;148:310-6.
56. Moinard J, Manier G, Pillet O, Castaing Y. Effect of inhaled nitric oxide on haemodynamics and VA/Q inequalities in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;149:1482-7.
57. Katayama Y, Higenbottam TW, Diaz de Atauri MJ, Cremona G, Akamine S, Barberà JA, et al. Inhaled nitric oxide and oxygen tension in patients with chronic obstructive pulmonary disease and severe pulmonary hypertension. Thorax 1997;52:120-4.
58. Torres A, Reyes A, Roca J, Wagner PD, Rodriguez-Roisin R. Ventilation-perfusion mismatching in chronic obstructive pulmonary disease during ventilator weaning. Am Rev Respir Dis 1989;140:1246-50.
59. Castaing Y, Manier G, Guernard H. Effect of 26% oxygen breathing on ventilation and perfusion distribution in patients with COLD. Bull Eur Physiopathol Respir 1985;21:17-23.
60. Walmrath D, Schneider T, Pilch J, Schermuly R, Grimminger F, Seeger W. Effects of aerosolised prostacyclin in severe pneumonia: impact of fibrosis. Am J Respir Crit Care Med 1995;151:724-30.
61. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993;23:499-502.
62. Yoshida M, Taguchi O, Gabaza EC, Kobayashi T, Yamakami T, Kobayashi H, et al. Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155:526-9.
63. Nacije R, Melot C, Mols P, Hallemans R, Naeije N, Cornil A, et al. Effects of almitrine in decompensated chronic respiratory insufficiency. Bull Eur Physiopathol Respir 1981;17:153-61.
64. Melot C, Naeije R, Rothschild T, Mertens P, Mols P, Hallemans R. Improvement in ventilation-perfusion matching in COPD. Chest 1983; 83:528-33.
65. Castaing Y, Manier G, Guenard H. Improvement in ventilation-perfusion relationships by almitrine in patients with chronic obstructive pulmonary disease during mechanical ventilation. Am Rev Respir Dis 1986;134:910-6.
66. Wysocki M, Delclaux C, Roupie E, Langeron O, Lui N, Herman B, et al. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome. Intensive Care Med 1994;20:254-9.
67. Prefaut C, Bourgouin-Karaouni D, Ramonataxo M, Michel FB, Macabies J. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy. Eur Respir J 1988; 1:41-50.
68. Weitzenblum E, Schriijen F, Apprill M, Prefaut C, Yernault JC. One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients. Eur Respir J 1991;4:1215-22.
69. Brett SJ, Evans TW. Inhaled vasodilator therapy in acute lung injury: first, do NO harm? Thorax 1995;50:821-3.